Event Participants
Executives
4 Sailesh Mehta, Subhash Anand, Suparas Jain, Tarun Sinha
Analysts
13 Adarsh Jain, Darshan Jhaveri, Hardik Shah, Harsh Shah, Meet Vora, Nirav Jimodia, Parth Sodha, Pritesh Chheda, Ranjit (IIFL Capital), Ritesh Bhagwati, Shubham Sharma, Viraj Mahadevia, Yash Gupta
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue | ₹3,256 crore | Up 22% YoY and 8% QoQ; driven by stronger realizations across ammonia, mining chemical and industrial chemical |
| Operating EBITDA | ₹845 crore | Up 65% YoY and 139% QoQ; highest-ever quarterly EBITDA, broad-based margin expansion across all businesses |
| EBITDA Margin | 26% | Improved from 19% YoY and ~12% in Q4 FY26; aided by realization gains, Equinor gas benefit and debottlenecking |
| Net Profit (PAT) | ₹490 crore | Up 101% YoY and 252% QoQ; Q1 alone covered >65% of FY26 full-year profit |
| Mining Chemical Revenue | ₹911 crore | Up 37% YoY despite volumes of 130 KT, temporarily impacted by PESO portal-driven supply chain disruption |
| Industrial Chemical Revenue | ₹490 crore | Nitric acid volumes stable with improved pricing from supply tightness; IPA volumes hit by propylene constraints |
| Crop Nutrition Revenue | ₹1,367 crore | Up 9% YoY despite delayed monsoon and subsidy misalignment; manufactured NPK volumes grew 4% |
| B2C Revenue (Mining) | ₹151 crore | Up 42% YoY; contributed 17% of segment revenue, improving earnings quality |
| Net Debt | ₹4,719 crore | Debt/EBITDA improved to 1.4x from 2.86x; near peak debt despite >₹500 crore quarterly CapEx |
| Ammonia Plant Utilization | 94% | Average for Q1; debottlenecked capacity ~10% higher; April gas issues resolved post-Equinor supply commencement |
Geographic & Segment Commentary
- Crop Nutrition: Revenue of ₹1,367 crore, up 9% YoY, despite delayed monsoon, elevated input costs and inadequate subsidy alignment. Manufactured NPK volumes grew 4%, Croptek remained steady, and specialty plus Croptek products contributed 40% of segment revenue. Q2 tailwind expected from widespread rains as El Niño concerns recede, though phosphoric acid/sulfur sourcing remains under strain from Middle East volatility.
- Mining Chemicals: Revenue of ₹911 crore, up 37% YoY, with volumes at 130 KT due to a temporary PESO portal guideline change that disrupted outward logistics for a few days — management clarified this was neither a demand nor raw material issue, and is fully normalized. B2C strategy gained traction at ₹151 crore (+42% YoY). Q2 will see typical monsoon-related slowdown; medium-to-long-term margins expected to remain consistent.
- Industrial Chemicals: Revenue of ~₹490 crore. Nitric acid volumes stable with improved pricing from supply tightness and lower imports; IPA volumes impacted by propylene availability constraints, but stronger pharma-grade demand and improved realizations supported profitability. IPA volumes expected to progressively recover as propylene availability improves.
- Ammonia & Integration: Plant ran at 94% utilization in Q1 after April gas issues were resolved with commencement of Equinor LNG supplies in May. ~80% of ammonia production is captive; surplus is sold as merchant ammonia. Debottlenecking delivered ~10% capacity improvement, and gas availability post-phase-in will be met entirely by Equinor.
Company-Specific & Strategic Commentary
- Equinor LNG Integration: 15-year LNG contract commenced with first cargo received in May 2026; legacy gas contracts are being phased out in parallel, with full Equinor phase-in expected by Q4 FY27. Management indicated commercially favorable savings, estimated at ~₹300 crore annually at current prices, varying with crude/Henry Hub dynamics.
- Gopalpur TAN Project:
96% complete; commissioning activities underway, plant expected operational by end Q2 FY27. Within approved CapEx envelope; cumulative project spend till Q1 was ₹3,850 crore. Faster ramp-up expected (80% utilization targeted by Q4 FY27) as chemistry/technology is already proven. - Hazira Nitric Acid Project: ~93% complete; commissioning expected Q2 FY27, within approved CapEx envelope. New plants will be depreciated over 25 years; long-term ammonia supply contracts are already tied up.
- Explosives Acquisition / DMSL: Acquired an explosives company in May 2026 to complete the mining value chain; facility being upgraded with new plant investments. DMSL operates an outcome-based TCO (total cost of ownership) model, distinct from input-driven competitors. Management is committed to listing DMSL; IPO versus demerger route under evaluation.
- Premiumization & B2C Shift: Specialty and Croptek products at 40% of crop nutrition revenue; B2C at 17% of mining chemical revenue, driving customer stickiness, preference and price premiums.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| New plant commissioning | Gopalpur TAN and Hazira nitric acid operational by end Q2 FY27; ~80% utilization targeted by Q4 FY27 | Faster ramp-up vs new entrants as technology is already proven; both plants within approved CapEx envelope |
| Ammonia prices | Elevated at ~$600 FOB Middle East for next 2–3 quarters | Even if Middle East war stops, prices not expected to revert to pre-war levels; a new elevated level likely to settle |
| Equinor gas phase-in | Full phase-in by Q4 FY27 | Legacy gas contracts phased out in parallel; Equinor will meet entire requirement post-completion; full-quarter benefit visible from Q2 onward |
| Deleveraging | Net debt to decline from FY27 onward | Peak debt reached; new capacities and integration to drive operating cash flow; both new businesses are working-capital efficient |
| FY27 earnings trajectory | Base level to be structurally elevated by FY27 year-end | Q3/Q4 contribution from new plants plus full-quarter Equinor benefits; management refrained from explicit full-year margin guidance |
| Q2 FY27 outlook | Mining slowdown due to monsoon; crop nutrition pickup | Widespread rains in geographies supportive; raw material (phosphoric acid, sulfur) sourcing strain and need for faster subsidy corrections noted |
Risks & Constraints
| Risk | Context |
|---|---|
| Middle East war volatility | Current conflict is supporting elevated realizations across TAN, ammonia and IPA and is net favorable, but supply-side disturbances and price swings remain unpredictable; management expects elevated prices to persist for at least 2–3 quarters, with a new higher normal likely |
| Potential Russian AN export ban | Global analysts indicate Russia may impose an ammonium nitrate export ban from October 2026 following Black Sea supply disruptions; would tighten global AN supply further, potentially extending elevated TAN pricing |
| Subsidy alignment & raw material costs | Delayed monsoon, elevated input costs and inadequate subsidy alignment strained crop nutrition in Q1; phosphoric acid and sulfur sourcing remains under pressure, requiring faster government subsidy corrections |
| Geopolitical external shocks | Management acknowledged external international factors can impact the business, though structural changes (Equinor gas, integration, specialty mix) are expected to reduce the severity of future volatility versus the 2022–2026 downcycle |
| Chinese/import competition | Historical risks of Russian FGAN dumping and Chinese nitroaromatic dumping drove the 2022–2026 downcycle; management believes structural positioning limits recurrence, but competitive import pressures remain a watch item |
Q&A Highlights
Ammonia plant utilization, debottlenecking & project ramp-up
- Question: What was capacity utilization for the ammonia plant given Q1 gas availability issues? Has the plant been debottlenecked beyond 500,000 tons? When will trial production start for new plants? (Hardik Shah, Brick Capital)
- Answer: Utilization averaged 94% for Q1 — April had gas issues, resolved post-May with Equinor supply. Plant has been debottlenecked with ~10% capacity improvement. Both projects on track for end-Q2 FY27 commissioning; ~80% utilization expected by Q4 FY27 if things go well, with faster ramp-up as the chemistry is proven. (Sailesh Mehta)
Industrial chemicals — structural outlook
- Question: How should industrial chemicals be viewed 2–3 years out? (Shubham Sharma, Aditya Birla Family Office)
- Answer: Nitric acid (CNA) is long-term contract-driven, stable and predictable with stable margins; IPA is more volatile but recovery has started with improving RGP availability. Long-term average margins should be maintained with quarterly volatility in IPA. (Sailesh Mehta)
TAN volume decline — cause and margin sustainability
- Question: Was the TAN volume drop due to raw material issues or market price unacceptability? How sustainable is current profitability? (Pritesh Chheda, Lucky Investments)
- Answer: Neither — PESO portal guideline change disrupted outward logistics for a few days, causing temporary production loss; fully normalized. Near-term margins remain elevated due to Middle East conflict and global supply crunch; medium-to-long-term margins expected consistent. (Sailesh Mehta, Tarun Sinha)
Structural change vs. the 2022–2026 downcycle
- Question: The June 2022 quarter EPS was matched only after four years of issues (Russian FGAN dumping, subsidy losses, IPA/nitroaromatic dumping). Will a similar downcycle recur? How long do elevated ammonia prices last? (Adarsh Jain, Individual Investor)
- Answer: Three structural changes — ammonia integration with Equinor gas, two new CapEx projects near commissioning, and the commodity-to-specialty/B2C shift — make severe volatility less likely, though normal business cycles will continue. Ammonia prices expected elevated for at least 2–3 quarters; even if the war stops, prices will not fall to prior levels quickly. (Sailesh Mehta)
Explosives strategy, TAN competition & depreciation
- Question: How will the explosives acquisition be positioned competitively? Any view on a major refiner entering TAN? How will depreciation move with new capacities? (Ranjit, IIFL Capital)
- Answer: The explosives acquisition completes the mining value chain; DMSL operates an outcome-based TCO model (guaranteeing productivity outcomes), distinct from input-driven explosive suppliers — a new space, not competition. No details available on the refiner's TAN entry; too early to comment. New plants depreciated over 25 years. (Tarun Sinha, Sailesh Mehta)
New plant feedstock, post-war supply-demand dynamics & gas mix
- Question: How is ammonia feedstock tied up for new plants? Will new capacities tilt the market long after the war? What is the Equinor share of gas supply? (Harsh Shah, Seven Rivers Holding)
- Answer: Long-term ammonia supply contracts are already tied up; TAN economics are evaluated with ammonia at market price (standalone profitability). Even with announced industry capacity additions, 6–7% demand growth keeps the market from turning drastically long; post-war normalization will take time — possibly a new normal. Equinor share ramps up as legacy contracts expire; government gas share will decline, not a fixed 70% plus top-up. (Sailesh Mehta)
Debt trajectory, working capital & FY27 shape
- Question: Where does net debt go over the next two years? Is interest capitalized? What working capital will new projects need? What is the risk over 6–12 months? (Yash Gupta, Think Site Advisory)
- Answer: Net debt of ~₹4,700–4,800 crore is near peak; some further debt may occur in the final project leg, then deleveraging starts this year. Project interest is capitalized. Both new businesses are working-capital efficient. FY27 base level will be structurally elevated by year-end. Risks are external/geopolitical, not execution-related; PESO disruption is behind us. (Sailesh Mehta)
Equinor savings quantum & nitric acid/merchant ammonia details
- Question: Post phase-in, how much of LNG requirement does Equinor cover? What annual savings (~₹300 crore mentioned by MD)? Were weak nitric acid volumes down? Merchant ammonia sales? (Nirav Jimodia, Anvil Wealth)
- Answer: Post phase-in (by Q4 FY27), Equinor will meet the entire requirement — no other gas source needed. Savings are sizable (~₹300 crore at current prices — consistent with MD's reference) and vary with crude/Henry Hub. Merchant nitric acid volumes were flat YoY; captive-to-merchant split is ~80/20. Surplus ammonia is sold as merchant ammonia as part of the normal business model. (Sailesh Mehta)
Russian AN export ban, ammonia price outlook & China supply
- Question: Given Black Sea disruptions, could Russia ban AN exports again? What is the current ammonia price and can Chinese exports offset tightness? (Meet Vora, JM Financial)
- Answer: Global analysts suggest Russia may impose an AN export ban from October 2026; that would tighten supply further. Ammonia is at ~$600 FOB Middle East; no immediate large-scale Chinese supply is coming to offset. Elevated prices are expected for 2–3 quarters, with a new elevated level likely to settle post-war. (Tarun Sinha, Sailesh Mehta)
DMSL corporate structure — IPO vs. demerger
- Question: Is the company leaning toward IPO or demerger/spin-off for DMSL? Demerger would align minority shareholders and aid SOTP valuation. (Ritesh Bhagwati, Alpha Plus Capital)
- Answer: The company is committed to listing DMSL; the route (IPO vs. demerger) is not yet decided. All options will be evaluated with stakeholder interests in mind, and the decision will be communicated in due course. (Sailesh Mehta)
Key Takeaway
Deepak Fertilisers delivered its best-ever quarter in Q1 FY27, with operating EBITDA of ₹845 crore (+65% YoY), PAT of ₹490 crore (+101% YoY) and revenue of ₹3,256 crore (+22% YoY), as elevated realizations across TAN, nitric acid, IPA and ammonia, combined with early Equinor LNG benefits, drove EBITDA margin to 26% and cut net debt/EBITDA from 2.86x to 1.4x. Strategic milestones included the first cargo under the 15-year Equinor LNG contract in May, a ~10% ammonia debottlenecking gain at 94% utilization, an explosives acquisition to complete the mining value chain, and Gopalpur TAN (96%) and Hazira nitric acid (93%) projects nearing end-Q2 FY27 commissioning — with ~80% utilization targeted by Q4 FY27. Management guided that Equinor gas phase-in completes by Q4 FY27, ammonia prices at ~$600 FOB Middle East remain elevated for 2–3 quarters with a new higher normal likely, and FY27's exit run-rate will be structurally elevated. Key watch points are Middle East war volatility, a potential Russian AN export ban from October 2026, fertilizer subsidy correction pace, and successful ramp-up of both new plants.